Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (241-250 of 342) with videos related to

Pageof 35
Sort By:
Neurology|April 19, 2022
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood OnsetEmilio Portaccio, Angelo Bellinvia, Lorenzo Razzolini, et al.
The Journal of Headache and Pain|February 15, 2019
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraineSimona Sacco, Silvia Benemei, Sabina Cevoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2021
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worseningEmilio Portaccio, Laura Tudisco, Luisa Pastò, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Tim Spelman, et al.
Neurology|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term DisabilitySifat Sharmin, Izanne Roos, Pierre M Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practiceTim Spelman, Claire Meyniel, Juan Ignacio Rojas, et al.
Neurology|August 11, 2017
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMSJohannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Pageof 35

Showing results (241-250 of 342) with videos related to

Sort By:
Pageof 35
Neurology|April 19, 2022
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood OnsetEmilio Portaccio, Angelo Bellinvia, Lorenzo Razzolini, et al.
The Journal of Headache and Pain|February 15, 2019
Development and validation of the ID-EC - the ITALIAN version of the identify chronic migraineSimona Sacco, Silvia Benemei, Sabina Cevoli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2021
Pregnancy in multiple sclerosis women with relapses in the year before conception increases the risk of long-term disability worseningEmilio Portaccio, Laura Tudisco, Luisa Pastò, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 1, 2017
Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Tim Spelman, et al.
Neurology|May 29, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term DisabilitySifat Sharmin, Izanne Roos, Pierre M Labauge, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 19, 2025
Age-dependent response to initial highly effective treatment in relapsing multiple sclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.
European Journal of Neurology|November 4, 2021
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosisRoberto Bergamaschi, Marta Ponzano, Irene Schiavetti, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 26, 2016
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practiceTim Spelman, Claire Meyniel, Juan Ignacio Rojas, et al.
Neurology|August 11, 2017
Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMSJohannes Lorscheider, Vilija G Jokubaitis, Tim Spelman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 19, 2020
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti, et al.
Pageof 35